SAB Biotherapeutics Stock (NASDAQ: SABS)
|Day Range0.68 - 0.86||52 Wk Range0.62 - 8.71||Open / Close0.7 / 0.78||Float / Outstanding26.4M / 43M|
|Vol / Avg.47.8K / 55.1K||Mkt Cap33.7M||P/E-||50d Avg. Price0.98|
|Div / Yield-||Payout Ratio-||Total Float26.4M||EPS-0.11|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of SAB Biotherapeutics (NASDAQ: SABS) through any online brokerage.
The latest price target for SAB Biotherapeutics (NASDAQ: SABS) was reported by Chardan Capital on Thursday, August 11, 2022. The analyst firm set a price target for 3.00 expecting SABS to rise to within 12 months (a possible 283.29% upside). 5 analyst firms have reported ratings in the last year.
The stock price for SAB Biotherapeutics (NASDAQ: SABS) is $0.7827 last updated September 26, 2022, 8:00 PM UTC.
There are no upcoming dividends for SAB Biotherapeutics.
SAB Biotherapeutics’s Q3 earnings are confirmed for Saturday, November 19, 2022.
There is no upcoming split for SAB Biotherapeutics.
SAB Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.